HOME >> MEDICINE >> NEWS
Parents' vaccine concerns on the rise, making accurate information crucial

ANN ARBOR, Mich. The doctors who treat America's children are hearing more and more concerns from their patients' parents about vaccines, and occasionally encountering parents who refuse some or all recommended vaccines for their children, according to a newly published study by University of Michigan researchers.

Many of the concerns heard by the nearly 750 pediatricians and family practice physicians surveyed for the study were about known, short-term effects from vaccines, such as pain and fever.

But many others were about unproven, or disproved, allegations that vaccines can cause everything from autism to diabetes, according to results published in the January issue of the American Journal of Preventive Medicine. The survey was performed in the year 2000, and funded by the Association of Teachers of Preventive Medicine and the Centers for Disease Control and Prevention.

And that, says lead researcher Gary Freed, M.D., M.P.H., means that children's doctors need to be understanding of parents' concerns, equipped with the latest information on vaccine safety, and ready to react to vaccination concerns or refusals.

As the "front lines" in the nation's vaccine delivery system, he says, physicians and other children's health providers need to help parents understand the benefits of vaccination, the state of knowledge on vaccine safety concerns, and the individual and societal risks of leaving their children unvaccinated.

"Physicians are in a unique position to both quantify parental concerns about vaccine safety, and provide information on the impact of those concerns on their decision making as parents," says Freed, the director of the Division of General Pediatrics at the U-M Health System and the Percy and Mary Murphy Professor of Pediatrics and Child Health Delivery at the U-M Medical School. "All of us must be sensitive to parents' concerns, and well prepared to respond to them."

Freed and his colleagues in th
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
16-Dec-2003


Page: 1 2 3 4

Related medicine news :

1. Parents heart attack or stroke raises risk in their middle-aged children
2. Parents smoke injures childrens blood vessels
3. Parents language barrier may prevent eligible children from receiving government-sponsored health insurance, says study
4. University Of North Carolina-Chapel Hill (UNC-CH) Study: Parents Wishes, Uncertainty Determine Resuscitation Of Premature Infants
5. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
6. NIAID initiates trial of experimental avian flu vaccine
7. Study finds majority of women willing to accept cervical cancer vaccine for self and children
8. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
9. Earlier use of prostate cancer vaccines urged by Hopkins scientists
10. Researchers close in on breast cancer vaccine
11. EuroVacc 02 HIV vaccine trial begins in February 2005

Post Your Comments:
(Date:5/21/2013)... ContinuCare Home Health, Inc. recently received a ... Disability Services. After completing a four-day review of patient ... Health was found to have no deficiencies to be ... Department of Aging and Disability Services’ mission to provide ... and opportunities that are easily accessed in local ...
(Date:5/21/2013)... 21, 2013 HealthSmart continues to grow ... presence has required the hiring of new talent in ... pleased to announce that Dawn Powell has joined the ... the Director of Account Management in the Central Region ... Irving, Texas. With extensive client management, employee benefits, and ...
(Date:5/21/2013)... May 2013, Paris, France: The Orsiro stent, which ... a biodegradable polymer, demonstrated non-inferiority to the Xience ... of in-stent late lumen loss at nine months ... at EuroPCR 2013 today. , The BIOFLOW-II substudy ... (OCT) to quantitatively assess neointimal hyperplasia and stent ...
(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Wright Conserve hip replacement lawsuits in ... an Order in response to a request from Plaintiffs’ ... of the Defendant. The May 17th Order grants ... interviews may be conducted. (In re: Wright Medical Technology, ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve the ... Creative Corridor region, is releasing results for its 2013 ... Thursday, May 23rd at 10:30 a.m. The survey ... , The survey is a critical component to the ... nurture and retain people of diverse backgrounds, cultures and ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2
(Date:5/21/2013)... 2013 BioElectronics Corp. (PINKSHEETS: BIEL), the ... announced that CEO, Andrew J. Whelan ... Medical Advisory Committee, Orthopedic and Rehabilitation Panel compelling ... the counter sales. "It,s been 37 ... classification schema," Whelan said.  "While the old classification ...
(Date:5/21/2013)... 2013  Janssen R&D Ireland (Janssen) today announced ... Phase 3 PROMISE study demonstrating that use of ... sustained virologic response 12 weeks after the end ... genotype 1 chronic hepatitis C adult patients with ... fibrosis, when administered once daily with pegylated interferon ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Reimbursement Scenario for Medical Devices in ...   Changing Regulatory ... the US Market   ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
Cached News: